128 related articles for article (PubMed ID: 3550623)
21. [Comparison of activity of fosfomycin, oxacillin and penicillin G against staphylococci and micrococci (author's transl)].
Peters G; Schumacher-Perdreau F; Pulverer G
Dtsch Med Wochenschr; 1980 Oct; 105(44):1541-3. PubMed ID: 6903495
[TBL] [Abstract][Full Text] [Related]
22. [Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
Ygout JF; Pasteau C; Mugnier P; Berlioux J; Daguet GL
Pathol Biol (Paris); 1988 Mar; 36(3):245-9. PubMed ID: 3283688
[TBL] [Abstract][Full Text] [Related]
23. Comparison of fosfomycin and teicoplanin in serum bactericidal activity against staphylococci.
Vogt K; Rauhut A; Trautmann M; Hahn H
Arzneimittelforschung; 1995 Aug; 45(8):894-7. PubMed ID: 7575756
[TBL] [Abstract][Full Text] [Related]
24. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa].
Schröter G; Schrettenbrunner A
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589
[No Abstract] [Full Text] [Related]
25. In vitro additive effect of imipenem combined with vancomycin against multiple-drug resistant, coagulase-negative Staphylococci.
Traub WH; Spohr M; Bauer D
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Sep; 262(3):361-9. PubMed ID: 3466493
[TBL] [Abstract][Full Text] [Related]
26. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
Zemelman R; González C; Mondaca MA
Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
[No Abstract] [Full Text] [Related]
27. Cephalosporins, vancomycin, aminoglycosides and other drugs, especially in combination, for the treatment of methicillin-resistant staphylococcal infections.
Klastersky J; Van der Auwera P
J Antimicrob Chemother; 1986 Mar; 17 Suppl A():19-24. PubMed ID: 2940212
[TBL] [Abstract][Full Text] [Related]
28. [Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Zuccarelli M; Simeon de Buochberg M; Maillols H; Dusart G; Attisso MA
Pathol Biol (Paris); 1988 May; 36(5):410-3. PubMed ID: 3136423
[TBL] [Abstract][Full Text] [Related]
29. Effects of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells.
Desnottes JF; Diallo N; Moret G; Santonja R
Drugs Exp Clin Res; 1987; 13(2):69-73. PubMed ID: 3472868
[TBL] [Abstract][Full Text] [Related]
30. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Martino P; Venditti M; Valente B; Brandimarte C; Serra P
Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
[TBL] [Abstract][Full Text] [Related]
31. [In vitro activity of fusidic acid in combination with various antibiotics against Staphylococcus epidermidis].
Fosse T; Appert A; Delpech D; Laffont C
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):621-5. PubMed ID: 3054737
[TBL] [Abstract][Full Text] [Related]
32. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin.
Graninger W; Leitha T; Breyer S; Francesconi M; Lenz K; Georgopoulos A
Drugs Exp Clin Res; 1985; 11(1):23-7. PubMed ID: 3869801
[TBL] [Abstract][Full Text] [Related]
33. [Importance of the antimicrobial mode of action of antibiotics for their combined effect with glycine in subinhibitory concentrations on microbial growth].
Gillissen G; Schumacher M; Breuer-Werle M
Pathol Biol (Paris); 1991 May; 39(5):451-4. PubMed ID: 1881674
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of fleroxacin in combination with other antimicrobial agents.
Neu HC; Chin NX
Am J Med; 1993 Mar; 94(3A):9S-16S. PubMed ID: 8452190
[TBL] [Abstract][Full Text] [Related]
35. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
[TBL] [Abstract][Full Text] [Related]
36. In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.
Matsuda K; Asahi Y; Sanada M; Nakagawa S; Tanaka N; Inoue M
J Antimicrob Chemother; 1991 Jun; 27(6):809-15. PubMed ID: 1938687
[TBL] [Abstract][Full Text] [Related]
37. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of lauric acid or myristylamine in combination with six antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA).
Kitahara T; Aoyama Y; Hirakata Y; Kamihira S; Kohno S; Ichikawa N; Nakashima M; Sasaki H; Higuchi S
Int J Antimicrob Agents; 2006 Jan; 27(1):51-7. PubMed ID: 16318911
[TBL] [Abstract][Full Text] [Related]
40. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
